Experimental set up to determine the impact of DNase treatment of ISP phage stocks with different storage periods (ISP-1, ISP-2 and ISP-3) on the quantification with qPCR and the a... by Saar Van Overfelt (20378458)

Subjects:

The catalase enzyme response of <i>A</i>. <i>albopictus</i> larvae decreased (1.5-fold) in response to <i>M</i>. <i>robertsii</i>-derived copper nanoparticles. by Perumal Vivekanandhan (4863484)

Subjects:

Cesarean section rate 2003-2017 among HSJ, control and Denmark. by Eva Rydahl (6260771)

Subjects:

Baseline characteristics for HSJ, control and Denmark (without HSJ) in the preintervention period, N = 289.045. by Eva Rydahl (6260771)

Subjects:

Cesarean section. by Eva Rydahl (6260771)

Subjects:

Flow chart of study participants. by Eva Rydahl (6260771)

Subjects:

Timeseries analyses HSJ trend before- and during intervention. by Eva Rydahl (6260771)

Subjects:

Absolute numbers among CS groups. by Eva Rydahl (6260771)

Subjects:

HSJ and controls stratified by timing for CS and parity. by Eva Rydahl (6260771)

Subjects:

Infection-mediated changes in transcripts related to thrombosis, coagulation and platelet-leukocyte interactions in platelets and leukocytes. by Heather Learnard (22075952)

The activity of representative Fe-S containing enzymes and mitochondrial membrane potential decreased in <i>ssr1-2</i> mutant, and were restored by <i>sus1</i> or <i>sus2</i>. by Xuanjun Feng (8768193)

a) ECM components and collagen structure change with tumor progression, which influences cancer cell proliferation and metastasis. b) SHG visual representation of collagen patterns... by Zoë Dinkel (21402766)

Subjects:

Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress. by Yongqin Wu (272012)

“…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …”

Average Heart Rate across pre-interview, interview and post-interview phases for High and Low Clarity and Authority groups: Heart Rate (HR) increases from pre-interview to intervie... by David Vagni (8060432)

Subjects:

(a) Mycelial diameter (mm) determination on PDA plates, (b) Inhibition diameters, and (c) inhibition percentages of <i>Aspergillus flavus</i> treated with <i>U. epigea</i> extract... by Martha Cebile Jobe (21175426)

Subjects:

Qualitative analyses of <i>U. epigea</i> bulb phytochemicals. by Martha Cebile Jobe (21175426)

Subjects:

Nucleotide sequence alignment of aflatoxin genes <i>Nor, Omt</i>, <i>Ver</i> and <i>aflR</i> treated with <i>U. epigea</i> extract, Ag/ZnO (Biosynthesized and Conventional) nanopar... by Martha Cebile Jobe (21175426)

Subjects:

<i>Aspergillus flavus</i> mRNA expression (a) <i>aflD</i> and (c) <i>aflR</i> and phylogenetic analysis of (b) <i>aflD</i> and (d) <i>aflR</i> after exposure to 50 mg/mL of <i>U. e... by Martha Cebile Jobe (21175426)

Subjects:

Primer pairs and PCR conditions used for amplification of selected Aflatoxin PCR gene primer pairs and their condition. by Martha Cebile Jobe (21175426)

Subjects:

Decomposition analysis of the changes in the number of deaths from hypertension-attributable AA in different SDI regions from 1990 to 2021. by Guanghui Yu (423945)

Subjects: